Published in Schizophr Bull on February 17, 2008
Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry (2011) 3.53
A prospective longitudinal volumetric MRI study of superior temporal gyrus gray matter and amygdala-hippocampal complex in chronic schizophrenia. Schizophr Res (2009) 1.82
Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies. Schizophr Bull (2011) 1.78
Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. Mol Psychiatry (2010) 1.49
Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic models. Schizophr Bull (2009) 1.44
Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. Neurosci Biobehav Rev (2013) 1.40
Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies. Transl Psychiatry (2012) 1.29
In vivo measurements of glutamate, GABA, and NAAG in schizophrenia. Schizophr Bull (2012) 1.28
Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting. Schizophr Bull (2009) 1.26
Global white matter abnormalities in schizophrenia: a multisite diffusion tensor imaging study. Schizophr Bull (2009) 1.25
Biomarkers and clinical staging in psychiatry. World Psychiatry (2014) 1.22
The myth of schizophrenia as a progressive brain disease. Schizophr Bull (2012) 1.21
Heritability of multivariate gray matter measures in schizophrenia. Twin Res Hum Genet (2012) 1.14
Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications. Handb Exp Pharmacol (2012) 1.12
Negative schizophrenic symptoms and the frontal lobe syndrome: one and the same? Eur Arch Psychiatry Clin Neurosci (2010) 1.09
Longitudinal brain changes in early-onset psychosis. Schizophr Bull (2008) 1.06
Stress and neurodevelopmental processes in the emergence of psychosis. Neuroscience (2013) 1.05
Concise review: the promise of human induced pluripotent stem cell-based studies of schizophrenia. Stem Cells (2011) 1.04
Cognitive deficits in recent-onset and chronic schizophrenia. J Psychiatr Res (2009) 1.03
Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry (2015) 1.01
Progressive structural brain changes during development of psychosis. Schizophr Bull (2010) 1.01
Morphometric brain abnormalities in schizophrenia in a population-based sample: relationship to duration of illness. Schizophr Bull (2008) 0.99
Visual surround suppression in schizophrenia. Front Psychol (2013) 0.99
Structural neuroimaging in schizophrenia: from methods to insights to treatments. Dialogues Clin Neurosci (2010) 0.99
Normal human aging and early-stage schizophrenia share common molecular profiles. Aging Cell (2009) 0.99
GABA and glutamate in schizophrenia: a 7 T ¹H-MRS study. Neuroimage Clin (2014) 0.95
The neurobiology and treatment of first-episode schizophrenia. Mol Psychiatry (2014) 0.93
Structural abnormalities in cortical volume, thickness, and surface area in 22q11.2 microdeletion syndrome: Relationship with psychotic symptoms. Neuroimage Clin (2013) 0.93
DISC1 is associated with cortical thickness and neural efficiency. Neuroimage (2011) 0.91
Is early intervention for psychosis feasible and effective? Psychiatr Clin North Am (2012) 0.91
Correlations between ventricular enlargement and gray and white matter volumes of cortex, thalamus, striatum, and internal capsule in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2011) 0.91
Physical Exercise Keeps the Brain Connected: Biking Increases White Matter Integrity in Patients With Schizophrenia and Healthy Controls. Schizophr Bull (2015) 0.90
Neuropsychological testing and structural magnetic resonance imaging as diagnostic biomarkers early in the course of schizophrenia and related psychoses. Neuroinformatics (2011) 0.89
Longitudinal changes in total brain volume in schizophrenia: relation to symptom severity, cognition and antipsychotic medication. PLoS One (2014) 0.89
The development of psychotic disorders in adolescence: a potential role for hormones. Horm Behav (2013) 0.88
The structural neural substrates of persistent negative symptoms in first-episode of non-affective psychosis: a voxel-based morphometry study. Front Psychiatry (2012) 0.87
A family affair: brain abnormalities in siblings of patients with schizophrenia. Brain (2013) 0.87
Longitudinal progression of frontal and temporal lobe changes in schizophrenia. Schizophr Res (2012) 0.86
Volumetric changes in the basal ganglia after antipsychotic monotherapy: a systematic review. Curr Med Chem (2013) 0.84
From antipsychotic to anti-schizophrenia drugs: role of animal models. Trends Pharmacol Sci (2012) 0.84
Glutamate-mediated excitotoxicity in schizophrenia: a review. Eur Neuropsychopharmacol (2014) 0.84
A Meta-Analysis of Mismatch Negativity in Schizophrenia: From Clinical Risk to Disease Specificity and Progression. Biol Psychiatry (2015) 0.83
Plasma levels of 3-methoxy-4-hydroxyphenylglycol are associated with microstructural changes within the cerebellum in the early stage of first-episode schizophrenia: a longitudinal VBM study. Neuropsychiatr Dis Treat (2014) 0.83
[Not Available]. Open Neuroimag J (2009) 0.83
A multi-scanner study of subcortical brain volume abnormalities in schizophrenia. Psychiatry Res (2014) 0.82
Structural alterations of the social brain: a comparison between schizophrenia and autism. PLoS One (2014) 0.82
Glucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefits. BMC Med (2012) 0.81
Decreased default mode neural modulation with age in schizophrenia. Am J Geriatr Psychiatry (2010) 0.81
Cortical thickness as a contributor to abnormal oscillations in schizophrenia? Neuroimage Clin (2013) 0.81
Aging effects on regional brain structural changes in schizophrenia. Schizophr Bull (2011) 0.80
Early auditory gamma-band responses in patients at clinical high risk for schizophrenia. Suppl Clin Neurophysiol (2013) 0.80
Profile of minocycline and its potential in the treatment of schizophrenia. Neuropsychiatr Dis Treat (2014) 0.79
Osteoprotegerin levels in patients with severe mental disorders. J Psychiatry Neurosci (2010) 0.79
Brain-Wide Analysis of Functional Connectivity in First-Episode and Chronic Stages of Schizophrenia. Schizophr Bull (2017) 0.79
The NMDA Receptor and Schizophrenia: From Pathophysiology to Treatment. Adv Pharmacol (2016) 0.79
Developmental mechanisms in the prodrome to psychosis. Dev Psychopathol (2013) 0.79
Multicenter study of brain volume abnormalities in children and adolescent-onset psychosis. Schizophr Bull (2010) 0.78
Cortical thickness, gray matter volume, and white matter anisotropy and diffusivity in schizophrenia. Neuroradiology (2011) 0.78
Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade. J Psychiatry Neurosci (2016) 0.78
Prognosis in schizophrenia and the role of subjectivity. Schizophr Bull (2008) 0.78
Is there a degenerative process going on in the brain of people with Schizophrenia? Front Hum Neurosci (2009) 0.77
Limited Evidence for Association of Genome-Wide Schizophrenia Risk Variants on Cortical Neuroimaging Phenotypes. Schizophr Bull (2015) 0.77
The contribution of neuroimaging to understanding schizophrenia; past, present, and future. Schizophr Bull (2014) 0.76
Linking the developmental and degenerative theories of schizophrenia: association between infant development and adult cognitive decline. Schizophr Bull (2014) 0.76
Slow Progression of Cognitive Dysfunction of Alzheimer's Disease in Sexagenarian Women with Schizophrenia. Case Rep Psychiatry (2015) 0.75
Neuropsychology, autobiographical memory, and hippocampal volume in "younger" and "older" patients with chronic schizophrenia. Front Psychiatry (2015) 0.75
Dynamic endophenotypes and longitudinal trajectories: capturing changing aspects of development in early psychosis. J Psychiatry Neurosci (2016) 0.75
Structural MRI Differences between Patients with and without First Rank Symptoms: A Delusion? Front Psychiatry (2015) 0.75
Serum S100B Protein is Specifically Related to White Matter Changes in Schizophrenia. Front Cell Neurosci (2016) 0.75
Alteration of gray matter microstructure in schizophrenia. Brain Imaging Behav (2017) 0.75
Genetic influences on individual differences in longitudinal changes in global and subcortical brain volumes: Results of the ENIGMA plasticity working group. Hum Brain Mapp (2017) 0.75
Effects of childhood and adolescence physical activity patterns on psychosis risk-a general population cohort study. NPJ Schizophr (2017) 0.75
Cognitive correlates of neuroimaging abnormalities in the onset of schizophrenia: A case report. World J Psychiatry (2017) 0.75
The effect of duration of illness and antipsychotics on subcortical volumes in schizophrenia: Analysis of 778 subjects. Neuroimage Clin (2017) 0.75
Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci (1999) 18.57
Synaptic activity and the construction of cortical circuits. Science (1996) 11.13
A review of MRI findings in schizophrenia. Schizophr Res (2001) 8.95
Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry (1991) 5.36
Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry (2000) 4.84
Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br J Psychiatry (1998) 4.42
A review of diffusion tensor imaging studies in schizophrenia. J Psychiatr Res (2005) 4.34
Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry (2005) 4.31
White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry (2003) 4.25
Astrocytes promote myelination in response to electrical impulses. Neuron (2006) 4.23
Is schizophrenia a neurodevelopmental disorder? Br Med J (Clin Res Ed) (1987) 4.02
Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry (2005) 3.78
Cortical rewiring and information storage. Nature (2004) 3.67
Widespread functional disconnectivity in schizophrenia with resting-state functional magnetic resonance imaging. Neuroreport (2006) 3.65
Long-term sensory deprivation prevents dendritic spine loss in primary somatosensory cortex. Nature (2005) 3.41
Genetic influences on human brain structure: a review of brain imaging studies in twins. Hum Brain Mapp (2007) 3.15
Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet (1976) 3.14
Brain volumes in relatives of patients with schizophrenia: a meta-analysis. Arch Gen Psychiatry (2007) 2.70
Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? Arch Gen Psychiatry (2002) 2.48
A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch Gen Psychiatry (1998) 2.24
Diffusion tensor imaging in schizophrenia. Biol Psychiatry (2005) 2.14
Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr Bull (2005) 2.13
Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Arch Gen Psychiatry (2007) 2.13
Computerised tomography in schizophrenia 15 years on. Br J Psychiatry Suppl (1990) 2.09
Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry (2001) 2.02
Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study. Neuropsychopharmacology (2007) 1.98
Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder. Arch Gen Psychiatry (1986) 1.74
Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol Psychiatry (1999) 1.73
Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics. Am J Psychiatry (1999) 1.72
Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry (1994) 1.72
Ventricular enlargement in poor-outcome schizophrenia. Biol Psychiatry (1998) 1.70
Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Arch Gen Psychiatry (2002) 1.68
Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biol Psychiatry (2007) 1.58
Cortical brain development in nonpsychotic siblings of patients with childhood-onset schizophrenia. Arch Gen Psychiatry (2007) 1.55
Intelligence and brain size in 100 postmortem brains: sex, lateralization and age factors. Brain (2005) 1.47
Outcome of schizophrenia in relation to brain abnormalities. Schizophr Bull (1999) 1.46
Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine. Lancet (1995) 1.43
Focal gray matter density changes in schizophrenia. Arch Gen Psychiatry (2001) 1.27
Volume changes in gray matter in patients with schizophrenia. Am J Psychiatry (2002) 1.27
Structural brain imaging in schizophrenia: a selective review. Biol Psychiatry (1999) 1.22
Cerebral ventricular change over the first 10 years after the onset of schizophrenia. Psychiatry Res (2004) 1.17
Frequency based mutual information measures between clusters of brain regions in functional magnetic resonance imaging. Neuroimage (2007) 1.17
Focal white matter density changes in schizophrenia: reduced inter-hemispheric connectivity. Neuroimage (2004) 1.14
A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia. Schizophr Res (2001) 1.12
Gray matter abnormalities associated with duration of untreated psychosis. Schizophr Res (2006) 1.07
Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment. Am J Psychiatry (1996) 1.00
Stability of CT scan findings in schizophrenia: results of an 8 year follow-up study. J Neurol Neurosurg Psychiatry (1988) 0.97
Progression of cerebroventricular enlargement and the subtyping of schizophrenia. Psychiatry Res (1997) 0.96
Cerebral ventricular enlargement in schizophrenia. A preliminary follow-up study. Arch Gen Psychiatry (1986) 0.95
Volume reduction of the left planum temporale gray matter associated with long duration of untreated psychosis in schizophrenia: a preliminary report. Psychiatry Res (2007) 0.94
Ten year progressive ventricular enlargement in schizophrenia: an MRI morphometrical study. Psychiatry Clin Neurosci (2001) 0.91
Defining the course of brain structural change and plasticity in schizophrenia. Psychiatry Res (1999) 0.91
Longitudinal volumetric MRI study in first- and multiple-episode male schizophrenia patients. Psychiatry Res (2005) 0.91
Reduced thalamic volume in patients with chronic schizophrenia after switching from typical antipsychotic medications to olanzapine. Am J Psychiatry (2006) 0.84
Ventricle-to-brain ratio in schizophrenia: a controlled follow-up study. Biol Psychiatry (1989) 0.81
Time course of cerebral ventricular enlargement in schizophrenia supports the hypothesis of its neurodevelopmental nature. Schizophr Res (1997) 0.81
Three-year follow-up of older schizophrenics: extrapyramidal syndromes, psychiatric symptoms, and ventricular brain ratio. Biol Psychiatry (1991) 0.78
Anatomy of schizophrenia revisited. Schizophr Bull (1997) 0.78
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Efficiency of functional brain networks and intellectual performance. J Neurosci (2009) 4.25
Functionally linked resting-state networks reflect the underlying structural connectivity architecture of the human brain. Hum Brain Mapp (2009) 4.22
The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. J Am Acad Child Adolesc Psychiatry (2006) 3.86
Aberrant frontal and temporal complex network structure in schizophrenia: a graph theoretical analysis. J Neurosci (2010) 3.80
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
The relationship of DNA methylation with age, gender and genotype in twins and healthy controls. PLoS One (2009) 3.41
Genetic influences on human brain structure: a review of brain imaging studies in twins. Hum Brain Mapp (2007) 3.15
Aging effects on DNA methylation modules in human brain and blood tissue. Genome Biol (2012) 3.05
Affective state and decision-making in the Ultimatum Game. Exp Brain Res (2006) 2.91
Do women really have more bilateral language representation than men? A meta-analysis of functional imaging studies. Brain (2004) 2.86
Brain volumes in relatives of patients with schizophrenia: a meta-analysis. Arch Gen Psychiatry (2007) 2.70
Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis. Schizophr Res (2004) 2.61
Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum Brain Mapp (2009) 2.55
Cannabis use and age at onset of schizophrenia. Am J Psychiatry (2004) 2.49
Abnormal rich club organization and functional brain dynamics in schizophrenia. JAMA Psychiatry (2013) 2.47
High-cost, high-capacity backbone for global brain communication. Proc Natl Acad Sci U S A (2012) 2.42
Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch Gen Psychiatry (2003) 2.41
Auditory verbal hallucinations predominantly activate the right inferior frontal area. Brain (2008) 2.35
Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol Psychiatry (2008) 2.28
The association between brain volume and intelligence is of genetic origin. Nat Neurosci (2002) 2.21
Lateralization of amygdala activation: a systematic review of functional neuroimaging studies. Brain Res Brain Res Rev (2004) 2.05
Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study. Neuropsychopharmacology (2007) 1.98
Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects. Schizophr Bull (2012) 1.97
Genetic contributions to human brain morphology and intelligence. J Neurosci (2006) 1.97
Efficacy of slow repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in schizophrenia: a meta-analysis. J Clin Psychiatry (2007) 1.95
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry (2010) 1.90
Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology (2008) 1.88
Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis. J Clin Psychiatry (2011) 1.83
Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies. Schizophr Bull (2011) 1.78
Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). Am J Psychiatry (2009) 1.71
Genetic analysis of DNA methylation and gene expression levels in whole blood of healthy human subjects. BMC Genomics (2012) 1.70
Reduced proactive inhibition in schizophrenia is related to corticostriatal dysfunction and poor working memory. Biol Psychiatry (2011) 1.70
Strange feelings: do amygdala abnormalities dysregulate the emotional brain in schizophrenia? Prog Neurobiol (2005) 1.69
Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol. Br J Psychiatry (2005) 1.68
Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Arch Gen Psychiatry (2002) 1.68
Diagnostic stability in a Dutch psychosis incidence cohort. Br J Psychiatry (2004) 1.67
Impaired recognition and expression of emotional prosody in schizophrenia: review and meta-analysis. Schizophr Res (2007) 1.60
Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biol Psychiatry (2007) 1.58
Deactivation of the parahippocampal gyrus preceding auditory hallucinations in schizophrenia. Am J Psychiatry (2010) 1.55
Magnetic resonance imaging of boys with attention-deficit/hyperactivity disorder and their unaffected siblings. J Am Acad Child Adolesc Psychiatry (2004) 1.53
Repetitive transcranial magnetic stimulation over the right dorsolateral prefrontal cortex affects strategic decision-making. Neuroreport (2005) 1.52
Effects of δ9-tetrahydrocannabinol on human working memory function. Biol Psychiatry (2012) 1.51
Function of striatum beyond inhibition and execution of motor responses. Hum Brain Mapp (2005) 1.51
Sex steroids and brain structure in pubertal boys and girls. Psychoneuroendocrinology (2008) 1.50
The same or different? A phenomenological comparison of auditory verbal hallucinations in healthy and psychotic individuals. J Clin Psychiatry (2011) 1.49
Human brain changes across the life span: a review of 56 longitudinal magnetic resonance imaging studies. Hum Brain Mapp (2011) 1.48
A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes. PLoS One (2012) 1.45
Heritability of regional and global brain structure at the onset of puberty: a magnetic resonance imaging study in 9-year-old twin pairs. Hum Brain Mapp (2009) 1.43
Social behavior and autism traits in a sex chromosomal disorder: Klinefelter (47XXY) syndrome. J Autism Dev Disord (2008) 1.39
Auditory hallucinations elicit similar brain activation in psychotic and nonpsychotic individuals. Schizophr Bull (2011) 1.39
Can low-frequency repetitive transcranial magnetic stimulation really relieve medication-resistant auditory verbal hallucinations? Negative results from a large randomized controlled trial. Biol Psychiatry (2010) 1.34
Genetic correlations between brain volumes and the WAIS-III dimensions of verbal comprehension, working memory, perceptual organization, and processing speed. Twin Res (2003) 1.31
Reliability of brain volumes from multicenter MRI acquisition: a calibration study. Hum Brain Mapp (2004) 1.31
Cardiorespiratory effects on default-mode network activity as measured with fMRI. Hum Brain Mapp (2009) 1.30
Expectations and violations: delineating the neural network of proactive inhibitory control. Hum Brain Mapp (2012) 1.28
Increased gray-matter volume in medication-naive high-functioning children with autism spectrum disorder. Psychol Med (2005) 1.27
Volume changes in gray matter in patients with schizophrenia. Am J Psychiatry (2002) 1.27
Functional diffusion tensor imaging: measuring task-related fractional anisotropy changes in the human brain along white matter tracts. PLoS One (2008) 1.26
Heritability of changes in brain volume over time in twin pairs discordant for schizophrenia. Arch Gen Psychiatry (2008) 1.25
Chronic effects of cannabis use on the human reward system: an fMRI study. Eur Neuropsychopharmacol (2010) 1.24
Heritability of DTI and MTR in nine-year-old children. Neuroimage (2010) 1.22
Influence of genes and environment on brain volumes in twin pairs concordant and discordant for bipolar disorder. Arch Gen Psychiatry (2009) 1.22
Changes in cortical thickness during the course of illness in schizophrenia. Arch Gen Psychiatry (2011) 1.21
Tract-based analysis of magnetization transfer ratio and diffusion tensor imaging of the frontal and frontotemporal connections in schizophrenia. Schizophr Bull (2008) 1.21
Cognitive basis of hallucinations in schizophrenia: role of top-down information processing. Schizophr Res (2003) 1.20
Underestimated effect sizes in GWAS: fundamental limitations of single SNP analysis for dichotomous phenotypes. PLoS One (2011) 1.19
Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update. Schizophr Bull (2013) 1.18
Prevalence of 22q11.2 deletions in 311 Dutch patients with schizophrenia. Schizophr Res (2007) 1.16
Brain volumes as predictor of outcome in recent-onset schizophrenia: a multi-center MRI study. Schizophr Res (2003) 1.15
Focal white matter density changes in schizophrenia: reduced inter-hemispheric connectivity. Neuroimage (2004) 1.14
Expression QTL analysis of top loci from GWAS meta-analysis highlights additional schizophrenia candidate genes. Eur J Hum Genet (2012) 1.14
Can structural MRI aid in clinical classification? A machine learning study in two independent samples of patients with schizophrenia, bipolar disorder and healthy subjects. Neuroimage (2013) 1.14
Neuronal substrate of the saccadic inhibition deficit in schizophrenia investigated with 3-dimensional event-related functional magnetic resonance imaging. Arch Gen Psychiatry (2002) 1.13
Effects of gestational age and birth weight on brain volumes in healthy 9 year-old children. J Pediatr (2010) 1.12
The effects of physical exercise in schizophrenia and affective disorders. Eur Arch Psychiatry Clin Neurosci (2013) 1.11
Sex differences in handedness, asymmetry of the planum temporale and functional language lateralization. Brain Res (2008) 1.11
Psychiatric morbidity and X-chromosomal origin in a Klinefelter sample. Schizophr Res (2007) 1.10
The European First Episode Schizophrenia Trial (EUFEST): rationale and design of the trial. Schizophr Res (2005) 1.09
Emotional processing in a non-clinical psychosis-prone sample. Schizophr Res (2004) 1.09
Dopaminergic function in the psychosis spectrum: an [18F]-DOPA imaging study in healthy individuals with auditory hallucinations. Schizophr Bull (2012) 1.09
Effects of typical and atypical antipsychotics on the prepulse inhibition of the startle reflex in patients with schizophrenia. J Clin Psychopharmacol (2002) 1.09
Cannabis with high cannabidiol content is associated with fewer psychotic experiences. Schizophr Res (2011) 1.09
Within-subject variation in BOLD-fMRI signal changes across repeated measurements: quantification and implications for sample size. Neuroimage (2008) 1.08
X Chromosomal effects on social cognitive processing and emotion regulation: A study with Klinefelter men (47,XXY). Schizophr Res (2006) 1.08
Impaired cerebellar functional connectivity in schizophrenia patients and their healthy siblings. Front Psychiatry (2011) 1.08
Is autoimmune thyroiditis part of the genetic vulnerability (or an endophenotype) for bipolar disorder? Biol Psychiatry (2006) 1.07
Striatal dysfunction in schizophrenia and unaffected relatives. Biol Psychiatry (2006) 1.07
Brain plasticity and intellectual ability are influenced by shared genes. J Neurosci (2010) 1.06
Gray and white matter volume abnormalities in monozygotic and same-gender dizygotic twins discordant for schizophrenia. Biol Psychiatry (2004) 1.06
Classification of schizophrenia patients and healthy controls from structural MRI scans in two large independent samples. Neuroimage (2012) 1.05
Migration and schizophrenia. Curr Opin Psychiatry (2007) 1.05
Heritability of subcortical brain measures: a perspective for future genome-wide association studies. Neuroimage (2013) 1.05
Transcranial magnetic stimulation and functional MRI reveal cortical and subcortical interactions during stop-signal response inhibition. J Cogn Neurosci (2012) 1.05
A controlled study of brain structure in monozygotic twins concordant and discordant for schizophrenia. Biol Psychiatry (2004) 1.05
Dyskinesia and parkinsonism in antipsychotic-naive patients with schizophrenia, first-degree relatives and healthy controls: a meta-analysis. Schizophr Bull (2008) 1.05
The functional neuroanatomy of metrical stress evaluation of perceived and imagined spoken words. Cereb Cortex (2004) 1.04
Behavioral inhibition system (BIS), behavioral activation system (BAS) and schizophrenia: relationship with psychopathology and physiology. J Psychiatr Res (2006) 1.04
Gray and white matter density changes in monozygotic and same-sex dizygotic twins discordant for schizophrenia using voxel-based morphometry. Neuroimage (2006) 1.04